Table 1. Clinicopathological characteristics of patients with early and late locoregional recurrence at time of primary tumor detection.
ELR(<12m) (N=30) |
LLR(≥12m) (N=44) |
P | |
---|---|---|---|
Age | |||
<65 | 28(40.6%) | 41(59.4%) | |
≥65 | 2(40.0%) | 3(60.0%) | 0.980 |
Gender | |||
Male | 20(38.5%) | 32(61.5%) | |
Female | 10(45.5%) | 12(54.5%) | 0.575 |
T stage | |||
T1-T2 | 4(33.3%) | 8(66.7%) | |
T3-T4 | 26(41.9%) | 36(58.1%) | 0.579 |
N stage | |||
N0-N1 | 7(41.2%) | 10(58.8%) | |
N2-N3 | 23(40.4%) | 34(59.6%) | 0.951 |
Vascular invasion | |||
NO | 19(35.2%) | 35(64.8%) | |
YES | 11(55.0%) | 9(45.0%) | 0.123 |
Pathological type | |||
SRC | 5(33.3%) | 10(66.7%) | |
PDA | 20(45.5%) | 24(54.5%) | |
MDA | 4 (44.4%) | 5(55.6%) | |
HDA | 1 (16.7%) | 5(83.3%) | 0.524 |
SRC: signet-Ring Cell carcinoma
PDA: poor-differentiated adenocarcinom
MDA: middler-differentiated adenocarcinom
HAD: high-differentiated adenocarcinom